Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2024-03-08 2024-03-08
Drug Identification Number 02244292 02244292
Brand name FLOVENT HFA FLOVENT HFA
Common or Proper name fluticasone propionate inhalation aerosol fluticasone propionate inhalation aerosol
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE
Strength(s) 125MCG 125MCG
Dosage form(s) METERED-DOSE AEROSOL METERED-DOSE AEROSOL
Route of administration ORAL INHALATION ORAL INHALATION ORAL INHALATION ORAL INHALATION
Packaging size 1x60 1x60
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2024-01-23 2024-01-23
Estimated end date 2024-03-08 2024-03-08
Actual end date 2024-03-07 2024-03-07
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Available in the 1x120 dose format. Available in the 1x120 dose format.
Health Canada comments